Invesaro

Stocks LTRX Financial statements

Financial statements

LANTRONIX INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LANTRONIX INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue44.745.646.959.971.5130131160123121
Cost of revenue21.220.220.63338.574.174.90.380.220.26
Gross profit23.625.426.326.93355.656.364.451.752.9
Research and development7.967.759.089.6911.117.719.620.318.617.6
Selling, general and administrative15.816.315.919.620.834.536.940.236.237
Operating expenses23.824.626.837.436.460.662.967.262.757
Operating income-0.180.8-0.49-10.5-3.34-5.01-6.67-2.86-11-4.12
Interest expense0.020.020.240.28
Other non-operating income-0-0.01-0.020.08-0.20.05-0.070.01-0.10.09
Pre-tax income-0.210.78-0.27-10.6-3.85-7.19-8.23-3.77-11.6-3.9
Income tax0.070.10.140.14-0.2-1.830.750.75-0.240.28
Net income-0.280.68-0.41-10.7-4.04-5.36-8.98-4.52-11.4-4.18
EBITDA0.411.25-0.02-9.77-2.52-3.98-4.94-0.7-8.92-2.52
EPS, basic-0.020.04-0.02-0.42-0.14-0.16-0.25-0.12-0.29-0.10
EPS, diluted-0.020.04-0.02-0.42-0.14-0.16-0.25-0.12-0.29-0.10
Shares, basic (weighted)17.518.221.625.328.732.736.337.438.640.1
Shares, diluted (weighted)17.519.221.625.328.732.736.337.438.640.1

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents8.079.5718.37.699.7417.213.526.220.160.5
Receivables3.434.247.3911.413.526.327.731.325.125.3
Inventory6.968.4410.513.815.137.749.727.726.425.8
Other current assets0.370.690.060.192.762.35
Total current assets19.423.338.234.543.29096.68977.4117
Property, plant and equipment1.221.041.21.591.583.654.634.022.461.45
Lease right-of-use assets0.983.352.438.0411.69.578.427.43
Goodwill9.499.499.4915.815.820.827.827.831.131.1
Intangible assets012.49.3614.610.65.253.742.18
Other non-current assets0.050.060.070.230.240.330.470.60.620.76
Total assets30.133.948.967.972.6137152136124160
Accounts payable2.723.944.725.339.1220.612.410.313.317
Accrued liabilities3.082.812.062.664.944.732.435.843.474.82
Deferred revenue0.20.310.330.660.240.370.893.023.33.07
Short-term debt01.471.471.672.7433.070
Total current liabilities8.999.7311.515.822.935.546.430.230.432.1
Long-term debt03.682.2114.316.213.28.680
Lease liabilities1.78
Other non-current liabilities0.40.310.211.961.47.6811.511.510.28.99
Total liabilities9.441011.721.426.557.574.154.949.341.1
Total debt05.253.6815.91916.211.80
Paid-in capital211213226246250289296304308358
Retained earnings-190-190-189-200-204-210-219-223-234-239
Other comprehensive income0.370.370.370.370.370.370.370.370.370.34
Shareholders' equity20.723.837.346.546.179.977.681.474.4119
Total equity20.723.837.346.546.179.977.681.474.4119
Total liabilities and equity30.133.948.967.972.6137152136124160
Shares outstanding17.818.922.828.229.135.136.937.939.146.6

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-0.280.68-0.41-10.7-3.85-7.19-8.23-3.77-11.6-4.18
Depreciation and amortization0.590.440.460.770.821.031.742.162.081.6
Stock-based compensation0.911.171.873.643.586.256.218.346.136.27
Deferred income tax0000
Change in receivables-0.27-0.81-1.972.81-2.1-7.470.48-3.66.19-0.23
Change in inventory-0.38-1.48-2.533.37-1.29-15.3-8.6921.22.040.55
Change in payables-0.011.20.77-2.63.578.78-8.58-2.132.893.35
Cash from operations2.070.51-1.75-2.524.3-9.420.2418.67.299.88
Capital expenditures-0.24-0.23-0.89-0.57-0.78-2.12-2.67-1.48-0.51-0.61
Acquisitions0-13.40-23.6-4.650
Cash from investing-0.24-0.23-0.89-14-0.78-25.7-7.32-1.48-6.96-0.61
Debt issued05.89028.84.91008.8
Debt repaid-4.51-20.7
Stock issued0.531.4911.61.160.9134.21.251.010.3644.9
Cash from financing0.281.2211.45.9-1.4742.63.32-4.36-6.4631.1
Net change in cash2.111.5-10.62.057.48-3.7712.8-6.1440.4
Free cash flow1.840.28-2.64-3.093.52-11.5-2.4417.16.789.27
Interest paid0.020.020.020.220.31.491.561.921.330.62
Income taxes paid0.070.090.120.10.20.220.540.630.640.26

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $7.02 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin43.8%Gross profit / revenue.
Operating margin-3.4%Operating income / revenue.
EBITDA margin-2.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-3.2%Pre-tax income / revenue.
Net margin-3.5%Net income / revenue.
FCF margin7.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin8.2%Cash from operations / revenue.
Return on equity (ROE)-4.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-2.9%Net income / average total assets.
Return on invested capital (ROIC)-5.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue14.5%Research and development expense / revenue.
SG&A / revenue30.6%Selling, general and administrative expense / revenue.
Stock-based pay / revenue5.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.5%Capital expenditures / revenue.
D&A / revenue1.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-1.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-2.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y2.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-2.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y9.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y35.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y246.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y18.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y36.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y21.3%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y60.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y15.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y20.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y29.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y17.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y4.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y3.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y6.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio3.66xCurrent assets / current liabilities.
Quick ratio2.67x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.89x(Cash + short-term investments) / current liabilities.
Debt / equity0.00xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets0.0%Total debt / total assets.
Liabilities / assets25.6%Total liabilities / total assets.
Net debt-$60.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$85.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets20.7%(Goodwill + intangible assets) / total assets.
Tangible book value$86.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.85xRevenue / average total assets.
Fixed asset turnover61.9xRevenue / average property, plant and equipment.
Inventory turnover0.01xCost of revenue / average inventory.
Days inventory37,341 days365 x average inventory / cost of revenue.
Receivables turnover4.80xRevenue / average receivables.
Days sales outstanding76 days365 x average receivables / revenue.
Days payables21,635 days365 x average accounts payable / cost of revenue.
Cash conversion cycle15,782 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow6.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.10Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.10Net income per basic share, as reported (split-adjusted).
Revenue per share$3.01Revenue / diluted weighted shares.
FCF per share$0.23Free cash flow / diluted weighted shares.
Operating cash flow per share$0.25Cash from operations / diluted weighted shares.
Book value per share$2.56Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.85Tangible book value / shares outstanding.
Cash per share$1.30(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$279.3MShare price x shares outstanding.
Enterprise value$218.8MMarket cap + total debt - cash - short-term investments.
P/S2.31xMarket cap / revenue.
P/B2.34xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book3.25xMarket cap / tangible book value, when positive.
P/FCF30.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF28.3xMarket cap / cash from operations, when positive.
EV/Sales1.81xEnterprise value / revenue.
EV/FCF23.6xEnterprise value / free cash flow, when both are positive.
FCF yield3.3%Free cash flow / market cap.
Earnings yield-1.5%Net income / market cap (the inverse of P/E).
What was LANTRONIX INC's revenue in fiscal 2026?

LANTRONIX INC reported revenue of $120.9M for fiscal 2026, 1.6% lower than the year before.

Was LANTRONIX INC profitable in fiscal 2026?

No. It reported a net loss of $4.2M.

How much free cash flow did LANTRONIX INC generate in fiscal 2026?

Cash from operations of $9.9M minus capital expenditures of $612.0K left free cash flow of $9.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LANTRONIX INC